Clinical Trial Update: Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing concurrent chemoradiotherapy to cetuximab with radiotherapy after neoadjuvant chemotherapy in locally advanced squamous cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 2 | Status: UNKNOWN